| CAY10647 |
CAY10647 |
1253697-49-2 |
| PBI-4050 Sodium salt |
1254472-97-3 |
1254472-97-3 |
| 5-(9-isopropyl-2-Morpholino-9H-purin-6-yl)pyriMidin-2-aMine |
5-(9-ISOPROPYL-2-MORPHOLINO-9H-PURIN-6-YL)PYRIMIDIN-2-AMINE |
1246535-95-4 |
| MAK-683 |
CPD 1111 |
1951408-58-4 |
| PQR530 |
PQR530 |
1927857-61-1 |
| MTX-211 |
MTX-211 |
1952236-05-3 |
| Spiratisanin B |
绣线菊阿替生素B |
1902173-19-6 |
| QC6352 |
QC6352 |
1851373-36-8 |
| 5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride |
CHK1抑制剂 |
1234015-54-3 |
| 17-keto-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic Acid |
17-keto-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic Acid |
1233715-28-0 |
| VRT-1353385 |
VRT-1353385 |
1616113-45-1 |
| K 02288 |
K02288 |
1431985-92-0 |
| XMD17 109 |
XMD17 109 |
1435488-37-1 |
| (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[[3-hydroxy-2-(trideuteriomethyl)benzoyl]amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide |
(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[[3-hydroxy-2-(trideuteriomethyl)benzoyl]amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide |
1217629-70-3 |
| RILUZOLE-13C,15N2 |
利鲁唑-13C-15N2 |
1215552-03-6 |
| 2-Amino-3-methyl-N-[2-(4-morpholinyl)ethyl]-pentanamide dihydrochloride |
2-氨基-3-甲基-N-[2-(吗啉-4-基)乙基]戊酰胺二盐酸 |
1214672-15-7 |
| 3'-fluoro-α-Pyrrolidinopropiophenone (hydrochloride) |
3'-fluoro-α-Pyrrolidinopropiophenone (hydrochloride) |
1214940-15-4 |
| 4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine |
PF-05180999 |
1394033-54-5 |
| Desmethylene Paroxetine hydrochloride solution |
帕罗西汀杂质5 |
1394861-12-1 |
| WZ4002 |
WZ4002 |
1213269-23-8 |
QQ
